Institutional shares held 111 Million
1.1M calls
800K puts
Total value of holdings $37.9M
$374K calls
$271K puts
Market Cap $16.3M
48,020,700 Shares Out.
Institutional ownership 232.02%
# of Institutions 131


Latest Institutional Activity in APLT

Top Purchases

Q1 2025
Wealth Enhancement Advisory Services, LLC Shares Held: 14.8K ($5.02K)
Q1 2025
Capital Advisors, Ltd. LLC Shares Held: 1.84K ($625)
Q4 2024
Vestal Point Capital, LP Shares Held: 11.5M ($3.91M)
Q4 2024
Schonfeld Strategic Advisors LLC Shares Held: 8.76M ($2.98M)
Q4 2024
T. Rowe Price Investment Management, Inc. Shares Held: 5.42M ($1.84M)

Top Sells

Q1 2025
Sg Americas Securities, LLC Shares Held: 13.9K ($4.73K)
Q1 2025
Hennion & Walsh Asset Management, Inc. Shares Held: 301K ($102K)
Q1 2025
Rhumbline Advisers Shares Held: 130K ($44.1K)
Q1 2025
Mirae Asset Global Investments Co., Ltd. Shares Held: 3.82K ($1.3K)
Q1 2025
Rothschild Investment LLC Shares Held: 35 ($11.9)

About APLT

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.


Insider Transactions at APLT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
2.53M Shares
From 9 Insiders
Grant, award, or other acquisition 1.78M shares
Bona fide gift 748K shares
Sell / Disposition
2.12M Shares
From 6 Insiders
Open market or private sale 1.38M shares
Bona fide gift 748K shares

Track Institutional and Insider Activities on APLT

Follow Applied Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLT shares.

Notify only if

Insider Trading

Get notified when an Applied Therapeutics Inc. insider buys or sells APLT shares.

Notify only if

News

Receive news related to Applied Therapeutics Inc.

Track Activities on APLT